While immunotherapies get most of the headlines, targeted cancer treatments have revolutionized oncology in recent years, changing the lives of some patients by homing in on genetically defined tumors. Join STAT’s Damian Garde for this webinar, where he’ll take a look at some of the most important recently approved targeted therapies  and examine the pipeline of medicines yet to come. That means looking at the underlying science, the clinical data, and the often surprising costs associated with these drugs.